Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xellar Biosystems
Newton, Massachusetts, United Statesxellarbio.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
Xellar Biosystems develops an integrated "Wet-AI" platform combining proprietary organ-on-a-chip technology with machine learning/artificial intelligence to accelerate preclinical drug discovery. Their system enables high-content three-dimensional cell imaging, spatiotemporal analysis of cellular responses, multiomics profiling, and scalable automation for multiplexed screening. The company aims to bridge the gap between traditional preclinical studies and successful clinical trials by providing more physiologically relevant data through advanced in vitro human disease models.
- Therapeutic areas
- Other
- Modalities
- Organ-on-a-chip models (3D multicellular disease models)AI-driven drug discovery platformsMicrofluidic-based systems for in vitro modelingMultiomics profiling and imaging analysis
- Industry
- Non-Drug Biotech
Beyond the preview
Go deeper on Xellar Biosystems.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xellar Biosystems.